Granisetron 0.05-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: May/Jun 2006 - Hormone Replacement Therapy
View All Articles in Issue
Abstract: A formulation for preparing Granisetron 0.05-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, granisetron, nausea, vomiting, antiemetic agent, cancer chemotherapy, radiation therapy, selective 5-hydroxytryptamine 3 receptor antagonist, selective 5-HT3 blocker
Related Categories: CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY, ADVERSE DRUG EVENTS
Download in electronic PDF format for $35